CYBIN INC. current report, Q3 FY2023

Cybin Inc. Form 6-K Summary

Business Context and Reporting Period

Cybin Inc. filed a Form 6-K as a foreign private issuer for July 2023. The filing was signed and furnished on July 20, 2023, and identifies the company’s principal executive offices in Toronto, Ontario.

The filing includes an exhibit index referencing a news release dated July 20, 2023, but the text provided does not include the content of that release.

Financial Metrics and Liquidity

The provided filing text does not report revenue, net income or loss, cash flow, margins, debt, liquidity, capital expenditures, or other financial metrics.

Material Changes Versus Prior Period

The filing text does not provide financial statements, operating results, or a clear description of material changes versus a prior comparable period.

Guidance, Outlook, Risks, and Unusual Items

No guidance, outlook, management commentary, risk factors, contingencies, or unusual items are described in the provided filing text. These matters may be addressed in the referenced July 20, 2023 news release, which is not included.

Investor Verification Items

  • Obtain and review Exhibit 99.1, the July 20, 2023 news release.
  • Verify whether the referenced news release contains financial, operational, clinical, financing, or strategic updates.
  • Review Cybin’s latest periodic financial report for revenue, cash runway, liquidity, debt, operating losses, and development expenditures.
  • Confirm any material risks, contingencies, or forward-looking statements associated with the July 2023 update.